genedrive (LON:GDR) Trading 11.6% Higher – Still a Buy?

genedrive plc (LON:GDR) traded up 11.6% on Friday . The company traded as high as GBX 1.20 and last traded at GBX 1.20. 12,001,355 shares changed hands during trading, an increase of 62% from the average session volume of 7,390,355 shares. The stock had previously closed at GBX 1.08.

genedrive Stock Performance

The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52. The stock has a 50-day moving average price of GBX 0.97 and a 200-day moving average price of GBX 0.80. The company has a market capitalization of £12.36 million, a price-to-earnings ratio of -1.33 and a beta of -0.04.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.